Morning Briefing
Summaries of health policy coverage from major news organizations
To Cut Drug Costs, FDA Paves Way For Easier Approval Of Copycat Biologics
The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic drugs to market with the aim of making medicine more affordable and accessible for patients. (Payne, 10/29)
More on the high cost of prescription drugs 鈥
States are getting creative to reduce Medicaid drug costs, with pharmacy benefit managers increasingly forced to adapt. This year, states including Minnesota, Nevada and Virginia enacted laws to use one PBM for their Medicaid managed care programs. They joined Ohio and Kentucky, which already have single PBMs, and more states have adopted comparable models or are considering similar approaches. Under this policy framework, a state contracts with a single PBM that operates pharmaceutical benefits for all Medicaid managed care plans and their members. (Tong, 10/29)
Cigna鈥檚 decision to scrap controversial prescription drug rebates may be both a transformative moment for the pharmacy benefit manager sector and merely the latest stage in the industry鈥檚 evolution. Express Scripts, housed within Cigna鈥檚 Evernorth Health Services subsidiary, and leading pharmacy benefit managers such as CVS Health subsidiary CVS Caremark and UnitedHealth Group unit Optum Rx are recalibrating their business practices amid sustained fire from President Donald Trump, Congress, state legislators, regulators and smaller competitors. (Tong, 10/29)
In other news about the Trump administration 鈥
The cost of hiring help to care for an elderly or a sick person at home is skyrocketing. A labor shortage and surging demand from an aging population was already driving up prices, and now the White House's crackdown on immigration and funding cuts are making things worse. (Peck, 10/30)
The tobacco industry鈥檚 influence on public health policymaking in the U.S. is growing according to the latest report by the anti-smoking organization Action on Smoking & Health (ASH). ASH鈥檚 Tobacco Industry Interference Index 2025, provided first to The Hill, found that the U.S. scored an 89 out of 100 on the Global Tobacco Industry Interference Index, a survey used to measure how governments respond the interference by the tobacco industry. The U.S.鈥檚 score ranked it 98 out of 100 surveyed countries. (Choi, 10/30)
It's a major international disaster. And it comes in the wake of the Trump administration's dismantling of the world's largest aid agency, the United States Agency for International Development, along with the slashing of billions of dollars in foreign assistance. Hurricane Melissa, the most powerful Atlantic storm of this year, has torn through Jamaica and several other islands in the Caribbean, leaving a trail of devastation. With major flooding and power outages, Prime Minister Andrew Holness has declared the country a "disaster area." (Tanis, 10/29)
One of US President Donald Trump鈥檚 first actions against China following his re-election was to impose a 10% tariff on Chinese imports, punishing Beijing for what he described as its failure to curb illegal exports of fentanyl and the chemicals used to make it. Fentanyl 鈥 a powerful and highly addictive synthetic opioid 鈥 is often legally prescribed by doctors to treat post-surgery or chronic pain. But the drug, which is relatively cheap and easy to produce, is also found on the black market and its illicit versions have contributed to a rise in overdose deaths in the US over the past decade. (10/30)
Surgeon general nominee is scheduled for a virtual confirmation hearing today 鈥
Dr. Casey Means wants to give the Trump administration鈥檚 鈥淢ake America Healthy Again鈥 agenda a less polarizing touch when she becomes U.S. surgeon general, a role where her experience as a new mother will be front and center. The wellness author, picked by Health Secretary Robert F. Kennedy Jr. to be surgeon general, was due to give birth to her first child Tuesday, just days before her expected virtual Senate confirmation hearing Thursday. (Essley Whyte and Siddiqui, 10/30)